Next earnings date: 13 Oct 2025
Johnson & Johnson – NYSE:JNJ
Johnson & Johnson stock price today
$178.54
+33.48
+23.09%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 1 day
Johnson & Johnson stock price monthly change
-3.22%
month
Johnson & Johnson stock price quarterly change
-3.22%
quarter
Johnson & Johnson stock price yearly change
-7.23%
year
Johnson & Johnson key metrics
Market Cap | 346.46B |
Enterprise value | 364.99B |
P/E | 23.77 |
EV/Sales | 4.16 |
EV/EBITDA | 12.36 |
Price/Sales | 3.98 |
Price/Book | 4.97 |
PEG ratio | 2.00 |
EPS | 15.8 |
Revenue | 89.66B |
EBITDA | 30.34B |
Income | 38.47B |
Revenue Q/Q | -13.55% |
Revenue Y/Y | -6.84% |
Profit margin | 16.74% |
Oper. margin | 25.22% |
Gross margin | 69.05% |
EBIT margin | 25.22% |
EBITDA margin | 33.84% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeJohnson & Johnson stock price history
Johnson & Johnson stock forecast
Johnson & Johnson financial statements
Average Price Target
$178.88
Potential upside: 0.18%
Analysts Price target
Financials & Ratios estimates
| Jul 2023 | 25.54B | 5.14B | 20.14% |
|---|---|---|---|
| Oct 2023 | 21.34B | 26.02B | 121.94% |
| Dec 2023 | 21.39B | 4.04B | 18.93% |
| Mar 2024 | 21.38B | 3.25B | 15.22% |
| 2024-10-15 | 2.21 | 2.42 |
|---|
3.38%
Yield TTM
| Payout ratio | 79.71% |
|---|
| 2017 | 2.39% |
|---|---|
| 2018 | 2.76% |
| 2019 | 2.59% |
| 2022 | 2.45% |
| 2023 | 2.96% |
| Jul 2023 | 191686000000 | 115.27B | 60.14% |
|---|---|---|---|
| Oct 2023 | 166061000000 | 94.83B | 57.11% |
| Dec 2023 | 167558000000 | 98.78B | 58.96% |
| Mar 2024 | 171966000000 | 101.94B | 59.28% |
| Jul 2023 | 4.18B | -3.77B | -5.99B |
|---|---|---|---|
| Oct 2023 | 7.48B | 2.54B | -11.31B |
| Dec 2023 | 7.86B | -1.20B | -4.65B |
| Mar 2024 | 3.65B | -464M | 546M |
Johnson & Johnson alternative data
Johnson & Johnson Social Media Accounts
What are followers?
+0.58%
month
| May 2025 | 100867 |
|---|---|
| Jul 2025 | 101930 |
| Aug 2025 | 102518 |
+0.16%
month
| May 2025 | 976650 |
|---|---|
| Jul 2025 | 979018 |
| Aug 2025 | 980558 |
-0.01%
month
| May 2025 | 249135 |
|---|---|
| Jul 2025 | 250954 |
| Aug 2025 | 250922 |
Johnson & Johnson Iconic Brands
| 13 Aug 2023 | 44 | 25 | 7 | 7 | 0 |
|---|---|---|---|---|---|
| 20 Aug 2023 | 40 | 25 | 7 | 7 | 0 |
| 27 Aug 2023 | 39 | 23 | 7 | 7 | 0 |
| 3 Sep 2023 | 40 | 24 | 6 | 7 | 0 |
| 10 Sep 2023 | 43 | 23 | 6 | 7 | 1 |
| 17 Sep 2023 | 42 | 24 | 6 | 7 | 1 |
| 24 Sep 2023 | 43 | 25 | 7 | 8 | 1 |
| 1 Oct 2023 | 41 | 23 | 6 | 7 | 1 |
| 8 Oct 2023 | 45 | 23 | 7 | 8 | 0 |
| 15 Oct 2023 | 42 | 23 | 7 | 7 | 1 |
| 22 Oct 2023 | 37 | 22 | 6 | 6 | 1 |
| 29 Oct 2023 | 42 | 23 | 7 | 7 | 1 |
| 5 Nov 2023 | 44 | 24 | 7 | 12 | 1 |
| 12 Nov 2023 | 41 | 26 | 7 | 8 | 1 |
| 19 Nov 2023 | 47 | 26 | 8 | 7 | 1 |
| 26 Nov 2023 | 49 | 24 | 8 | 8 | 1 |
| 3 Dec 2023 | 49 | 23 | 8 | 7 | 1 |
| 10 Dec 2023 | 44 | 24 | 8 | 7 | 1 |
| 17 Dec 2023 | 50 | 26 | 8 | 7 | 1 |
| 24 Dec 2023 | 52 | 25 | 8 | 7 | 1 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Sep 2023 | 2,454 |
|---|---|
| Oct 2023 | 2,425 |
| Nov 2023 | 2,666 |
| Dec 2023 | 2,509 |
| Jan 2024 | 2,255 |
| Feb 2024 | 3,077 |
| Apr 2024 | 2,713 |
| May 2024 | 2,603 |
| Jun 2024 | 2,828 |
| Jul 2024 | 3,080 |
| Dec 2024 | 1,738 |
| Sep 2023 | 152,700 |
|---|---|
| Oct 2023 | 152,700 |
| Nov 2023 | 152,700 |
| Dec 2023 | 152,700 |
| Jan 2024 | 152,700 |
| Feb 2024 | 152,700 |
| Mar 2024 | 131,900 |
| Apr 2024 | 131,900 |
| May 2024 | 131,900 |
| Jun 2024 | 131,900 |
| Jul 2024 | 131,900 |
Johnson & Johnson other data
67.09%
-0.65%
of JNJ is owned by hedge funds
3.50K
-20
1.79B
-17.90M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Feb 2024 | 0 | 59397 |
| Mar 2024 | 0 | 8891 |
| Aug 2024 | 0 | 5635 |
| Dec 2024 | 1000 | 0 |
| Patent |
|---|
Grant Utility: Devices having system for reducing the impact of near distance viewing on myopia onset and/or myopia progression Filling date: 5 May 2021 Issue date: 20 Sep 2022 |
Grant Utility: Systems and methods of using absorptive imaging metrology to measure the thickness of ophthalmic lenses Filling date: 17 Feb 2020 Issue date: 20 Sep 2022 |
Grant Filling date: 4 Oct 2018 Issue date: 20 Sep 2022 |
Grant Filling date: 24 Apr 2019 Issue date: 6 Sep 2022 |
Grant Filling date: 3 Mar 2021 Issue date: 30 Aug 2022 |
Grant Filling date: 26 Feb 2020 Issue date: 23 Aug 2022 |
Grant Filling date: 25 Jun 2020 Issue date: 16 Aug 2022 |
Grant Filling date: 26 Feb 2020 Issue date: 16 Aug 2022 |
Grant Filling date: 28 Jun 2019 Issue date: 16 Aug 2022 |
Grant Filling date: 25 Feb 2020 Issue date: 2 Aug 2022 |
| Quarter | Transcript |
|---|---|
| Q1 2024 16 Apr 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 23 Jan 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 17 Oct 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 20 Jul 2023 | Q2 2023 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
| Mr. Alex Gorsky (1960) Executive Chairman | $5,000,000 |
| Mr. Joaquin Duato (1963) Chief Executive Officer & Director | $2,890,000 |
Mr. Joseph J. Wolk CPA (1967) Executive Vice President & Chief Financial Officer | $1,980,000 |
| Ms. Jennifer L. Taubert (1964) Executive Vice President & Worldwide Chairman of Pharmaceuticals | $1,920,000 |
Industry Analysis: Pharmaceuticals Like Novo Nordisk Offer Long-Term Opportunities
Why Johnson & Johnson Stock Still Has Room To Run
GSK: I Foresee Only Very Modest Upside Here Even If Blenrep Gets FDA Approval
Johnson & Johnson Stock Could Be Waking Up
Johnson & Johnson: The Worst Is Baked In
Mar Vista U.S. Quality Q2 2025 Top Contributors And Detractors
These Are The Most Overvalued And Undervalued Mega Cap Stocks
Merck & Co.: A Pharma Titan At A Discount
Globus Medical: Obtaining My Backing Again
-
What's the price of Johnson & Johnson stock today?
One share of Johnson & Johnson stock can currently be purchased for approximately $178.54.
-
When is Johnson & Johnson's next earnings date?
Johnson & Johnson is estimated to report earnings on Monday, 13 Oct 2025.
-
Does Johnson & Johnson pay dividends?
Yes, Johnson & Johnson pays dividends and its trailing 12-month yield is 3.39% with 80% payout ratio. The last Johnson & Johnson stock dividend of $1.06 was paid on 8 Mar 2022.
-
How much money does Johnson & Johnson make?
Johnson & Johnson has a market capitalization of 346.46B and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 9.19% to 85.16B US dollars. Johnson & Johnson earned 35.15B US dollars in net income (profit) last year or $2.42 on an earnings per share basis.
-
What is Johnson & Johnson's stock symbol?
Johnson & Johnson is traded on the NYSE under the ticker symbol "JNJ".
-
What is Johnson & Johnson's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers - General industry.
-
How do i buy shares of Johnson & Johnson?
Shares of Johnson & Johnson can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Johnson & Johnson's key executives?
Johnson & Johnson's management team includes the following people:
- Mr. Alex Gorsky Executive Chairman(age: 65, pay: $5,000,000)
- Mr. Joaquin Duato Chief Executive Officer & Director(age: 62, pay: $2,890,000)
- Mr. Joseph J. Wolk CPA Executive Vice President & Chief Financial Officer(age: 58, pay: $1,980,000)
- Ms. Jennifer L. Taubert Executive Vice President & Worldwide Chairman of Pharmaceuticals(age: 61, pay: $1,920,000)
-
How many employees does Johnson & Johnson have?
As Jul 2024, Johnson & Johnson employs 131,900 workers.
-
When Johnson & Johnson went public?
Johnson & Johnson is publicly traded company for more then 82 years since IPO on 2 Jan 1943.
-
What is Johnson & Johnson's official website?
The official website for Johnson & Johnson is jnj.com.
-
Where are Johnson & Johnson's headquarters?
Johnson & Johnson is headquartered at One Johnson & Johnson Plaza, New Brunswick, NJ.
-
How can i contact Johnson & Johnson?
Johnson & Johnson's mailing address is One Johnson & Johnson Plaza, New Brunswick, NJ and company can be reached via phone at +7 325240400.
-
What is Johnson & Johnson stock forecast & price target?
Based on 8 Wall Street analysts` predicted price targets for Johnson & Johnson in the last 12 months, the avarage price target is $178.88. The average price target represents a 0.18% change from the last price of $178.54.
Johnson & Johnson company profile:
Johnson & Johnson
jnj.comExchange:
NYSE
Full time employees:
131,900
Industry:
Drug Manufacturers - General
Sector:
Healthcare
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
One Johnson & Johnson Plaza
New Brunswick, NJ 08933
New Brunswick, NJ 08933
CIK: 0000200406
ISIN: US4781601046
CUSIP: 478160104
